Community Incidence Rates Research Articles

Effects of School-Based Preventive Measures on COVID-19 Incidence, Hong Kong, 2022.

We show that school closures reduced COVID-19 incidence rates in children by 31%-46% in Hong Kong in 2022. After school reopening accompanied by mask mandates, daily rapid testing, and vaccination requirements, school-reported cases correlated with community incidence rates. Safe school reopening is possible when appropriate preventive measures are used.

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland

Background: Many hospitals test all patients for SARS-CoV-2 upon admission to prevent silent transmission to other patients and healthcare workers. The utility of universal admission testing has been questioned, however, due to resource constraints, care delays, and sparse data on its impact on nosocomial infections. England and Scotland stopped requiring universal admission testing on August 31, 2022, and September 28, 2022, respectively. We assessed associations between these changes and hospital-onset SARS-CoV-2 infection rates. Methods: We used public data from National Health Service England and Public Health Scotland on hospital-onset SARS-CoV-2 infections, defined as cases diagnosed >7 days after admission, between July 1, 2021, and December 16, 2022. Because hospital-onset infections are driven by SARS-CoV-2 community incidence rates, we calculated the weekly ratio between hospital-onset versus community-onset SARS-CoV-2 admissions (diagnosed ≤7 days from admission) and assessed for temporal changes associated with stopping universal admission testing using interrupted time-series analysis. The study was divided into 3 periods: sARS-CoV-2 delta-variant dominance with admission testing, SARS-CoV-2 omicron-variant dominance with admission testing (starting December 14, 2021), and SARS-CoV-2 omicron-variant dominance without admission testing. Results: During the study period, there were 518,379 COVID-19 admissions in England, including 398,264 community-onset and 120,115 hospital-onset cases, and 46,517 COVID-19 admissions in Scotland, including 34,183 community-onset and 12,334 hospital-onset cases. The mean weekly ratio of new hospital-onset SARS-CoV-2 infections versus community-onset admissions in England rose from 0.12 during the SARS-CoV-2 delta-variant surge to 0.33 during the SARS-CoV-2 omicron-variant surge to 0.48 after universal admission testing ended (Fig.). There was a significant immediate level change both after the SARS-CoV-2 delta-to-omicron variant transition (92% relative increase; 95% CI, 58%–127%) and after admission testing ended (32% relative increase; 95% CI, 14%–50%). Likewise, the mean weekly ratios rose from 0.11 to 0.43 to 0.89 during their analogous periods in Scotland, with significant level changes both after SARS-CoV-2 delta-to-omicron variant transition (113% relative increase; 95% CI, 54%–172%) and after admission testing ended (72% relative increase; 95% CI, 43%–100%). No significant trend changes were observed. Conclusions: Stopping asymptomatic screening of hospitalized patients in 2 national health systems was associated with significant increases in hospital-onset SARS-CoV-2 infections. Nosocomial SARS-CoV-2 remains a common and potentially morbid complication, with reported mortality rates for nosocomial infections by SARS-CoV-2 omicron variant ranging from 5% to 13%. Preventing infections in vulnerable populations remains an important safety goal. Hospitals should exercise caution when considering reductions in SARS-CoV-2 admission screening.Disclosures: None

Association of physical restraint duration and undesirable outcomes amongst inpatients comorbid with dementia and pneumonia in acute care settings.

This study aimed to examine the association between physical restraint duration and undesirable outcomes amongst inpatients comorbid with dementia and pneumonia in acute care hospitals. Physical restraints are frequently used in the management of patients, especially amongst patients with dementia. No previous study investigated the potential undesirable effects of physical restraints in patients with dementia. This was a cohort study using a nationwide discharge abstract database in Japan. Patients aged ≥65 years with dementia hospitalised for pneumonia or aspiration pneumonia between April 1, 2016 and March 31, 2019 were identified. The exposure was physical restraint. The primary outcome was hospital discharge to the community. Secondary outcomes included hospitalisation costs, functional decline, in-hospital mortality, and institutionalisation for long-term care. A total of 18,255 inpatients with pneumonia and dementia in 307 hospitals were included in this study. Of them, 21.5% and 23.7% had physical restraint during full and partial days of hospital stays, respectively. Discharge to the community incidence rates was lower in the full-restraint vs. the no-restraint group (27 vs. 29 per 1000 person-days; HR, 1.05 [95% CI, 1.01-1.10]) and the partial-restraint vs. the no-restraint group (17 vs. 29 per 1000 person-days; HR, 1.79 [95% CI, 1.71-1.87]). The risks of functional decline were higher in the full-restraint vs. the no-restraint group (27.8% vs. 20.8%; RR, 1.33 [95% CI, 1.22, 1.46]) and the partial-restraint vs. the no-restraint group (29.2% vs. 20.8%; RR, 1.40 [95% CI, 1.29, 1.53]). The use of physical restraints was associated with a lower incidence rate of discharge to the community and an increased risk of functional decline at discharge. Further research is needed to judge the benefit-risk balance of physical restraints in acute care settings. Understanding the risk of physical restraints allows medical staff to improve the process of decision making in everyday practice. No Patient or Public Contribution. The reporting of this article conforms to the STROBE statement.

Universal admission laboratory screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) asymptomatic infection across a large health system

Admission laboratory screening for asymptomatic coronavirus disease 2019 (COVID-19) has been utilized to mitigate healthcare-associated severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission. An understanding of the impact of such testing across a variety of patient populations is needed. SARS-CoV-2 nucleic acid amplification admission testing results for all asymptomatic patients across 4 distinct inpatient facilities between April 20, 2020, and June 14, 2021, were analyzed. Positivity rates and the number needed to test (NNT) to identify 1 asymptomatic infected patient were calculated. Admission results were compared to COVID-19 community incidence rates for the system's surrounding metropolitan service area. Using a national survey of hospital epidemiologists, a clinically meaningful NNT of 1:100 was identified. In total, 51,187 tests were collected (positivity rate, 1.8%). During periods of high transmission, the NNT met the clinically relevant threshold in all populations. The NNT approached or met the threshold for most locations during periods of lower transmission. For all transmission levels, the NNT for fully vaccinated patients did not meet the threshold. Implementing an asymptomatic patient admission testing program can provide clinically relevant data based on the NNT, even during periods of lower transmission and among different patient populations. Limiting admission testing to non-fully vaccinated patients during periods of lower transmission may be a strategy to address resource concerns around this practice. Although the impact of such testing on healthcare-associated COVID-19 among patients and healthcare workers could not be clearly determined, these data provide important information as facilities weigh the costs and benefits of such testing.

Adaptive Sentinel Testing in Workplace for COVID-19 Pandemic.

Testing and isolation of infectious employees is one of the critical strategies to make the workplace safe during the pandemic for many organizations. Adaptive testing frequency reduces cost while keeping the pandemic under control at the workplace. However, most models aimed at estimating test frequencies were structured for municipalities or large organizations such as university campuses of highly mobile individuals. By contrast, the workplace exhibits distinct characteristics: employee positivity rate may be different from the local community because of rigorous protective measures at workplace, or self-selection of co-workers with common behavioral tendencies for adherence to pandemic mitigation guidelines. Moreover, dual exposure to COVID-19 occurs at work and home that complicates transmission modeling, as does transmission tracing at the workplace. Hence, we developed bi-modal SEIR (Susceptible, Exposed, Infectious, and Removed) model and R-shiny tool that accounts for these differentiating factors to adaptively estimate the testing frequency for workplace. Our tool uses easily measurable parameters: community incidence rate, risks of acquiring infection from community and workplace, workforce size, and sensitivity of testing. Our model is best suited for moderate-sized organizations with low internal transmission rates, no-outward facing employees whose position demands frequent in-person interactions with the public, and low to medium population positivity rates. Simulations revealed that employee behavior in adherence to protective measures at work and in their community, and the onsite workforce size have large effects on testing frequency. Reducing workplace transmission rate through workplace mitigation protocols and higher sensitivity of the test deployed, although to a lesser extent. Furthermore, our simulations showed that sentinel testing leads to only marginal increase in the number of infections even for high community incidence rates, suggesting that this may be a cost-effective approach in future pandemics. We used our model to accurately guide testing regimen for three campuses of the Jackson Laboratory.

Analysis of Universal admission laboratory screening for SARS-CoV-2 asymptomatic infection across a large health system

Background: Admission laboratory screening for asymptomatic COVID-19 has been utilized to mitigate healthcare-associated SARS-CoV-2 transmission. A better understanding of the impact of such testing across a variety of patient populations is needed. Methods: Beginning April 2020, every patient admitted within an academic healthcare system underwent SARS-CoV-2 PCR testing upon admission. Between April 20, 2020 through June 14, 2021, results were analyzed in asymptomatic patients across 4 inpatient facilities: a tertiary-care adult hospital, a free-standing pediatric hospital, a community-based hospital, and a behavioral health hospital. Positivity rates and the number needed to test (NNT) to identify 1 asymptomatic infected patient were calculated overall, by hospital type, by patient vaccination status, and by CDC-defined levels of community transmission. Weekly community incidence rates of COVID-19 for the system’s metropolitan service area (8 central Tennessee counties) were obtained from Tennessee Department of Health records. Weekly COVID-19 incidence rates per 100,000 people were calculated using US Census Bureau data. Using a national survey of hospital epidemiologists, a clinically meaningful NNT was identified (ie, 1 positive patient per 100 patients tested). A crude admission testing cost (covering testing supplies, reagents, and lab personnel costs) was obtained from operational data ($50 per test) to assess testing utility. Results: In total, 51,187 tests were collected during the study period with a positivity rate of 1.8%. No periods of low transmission were observed (Table 1). During high transmission periods, the NNT met the clinically relevant threshold in all populations. In addition, the NNT approached or met the 1:100 threshold for most locations during periods of less transmission, suggesting continued benefit even as infection rates decline. In all transmission periods, the NNT for non–fully vaccinated patients met the clinically meaningful threshold, in contrast to testing of fully vaccinated patients (Table 2). Discussion: Implementing an asymptomatic patient admission testing program can provide clinically relevant value based on the NNT, even during lower periods of transmission and in different patient populations. Limiting admission testing to non–fully vaccinated patients during periods of lower transmission may be a strategy to address cost and resource concerns around this practice. Further investigations into the impact of booster vaccination and newer SARS-CoV-2 variants on admission testing programs are also necessary. Although the impact of such testing on healthcare-associated COVID-19 among patients and healthcare workers could not be clearly determined, these data provide important information as facilities weigh the costs and benefits of such testing.Funding: NoneDisclosures: None

SARS-CoV-2 Saliva Mass Screening in Primary Schools: A 10-Week Sentinel Surveillance Study in Munich, Germany.

Representative, actively collected surveillance data on asymptomatic SARS-CoV-2 infections in primary schoolchildren remain scarce. We evaluated the feasibility of a saliva mass screening concept and assessed infectious activity in primary schools. During a 10-week period from 3 March to 21 May 2021, schoolchildren and staff from 17 primary schools in Munich participated in the sentinel surveillance, cohort study. Participants were tested using the Salivette® system, testing was supervised by trained school staff, and samples were processed via reverse transcription quantitative polymerase chain reaction (RT-qPCR). We included 4433 participants: 3752 children (median age, 8 [range, 6–13] years; 1926 girls [51%]) and 681 staff members (median age, 41 [range, 14–71] years; 592 women [87%]). In total, 23,905 samples were processed (4640 from staff), with participants representing 8.3% of all primary schoolchildren in Munich. Only eight cases were detected: Five out of 3752 participating children (0.13%) and three out of 681 staff members (0.44%). There were no secondary cases. In conclusion, supervised Salivette® self-sampling was feasible, reliable, and safe and thus constituted an ideal method for SARS-CoV-2 mass screenings in primary schoolchildren. Our findings suggest that infectious activity among asymptomatic primary schoolchildren and staff was low. Primary schools appear to continue to play a minor role in the spread of SARS-CoV-2 despite high community incidence rates.

Current Insights Into Respiratory Virus Transmission and Potential Implications for Infection Control Programs : A Narrative Review.

Policies to prevent respiratory virus transmission in health care settings have traditionally divided organisms into Droplet versus Airborne categories. Droplet organisms (for example, influenza) are said to be transmitted via large respiratory secretions that rapidly fall to the ground within 1 to 2 meters and are adequately blocked by surgical masks. Airborne pathogens (for example, measles), by contrast, are transmitted by aerosols that are small enough and light enough to carry beyond 2 meters and to penetrate the gaps between masks and faces; health care workers are advised to wear N95 respirators and to place these patients in negative-pressure rooms. Respirators and negative-pressure rooms are also recommended when caring for patients with influenza or SARS-CoV-2 who are undergoing "aerosol-generating procedures," such as intubation. An increasing body of evidence, however, questions this framework. People routinely emit respiratory particles in a range of sizes, but most are aerosols, and most procedures do not generate meaningfully more aerosols than ordinary breathing, and far fewer than coughing, exercise, or labored breathing. Most transmission nonetheless occurs at close range because virus-laden aerosols are most concentrated at the source; they then diffuse and dilute with distance, making long-distance transmission rare in well-ventilated spaces. The primary risk factors for nosocomial transmission are community incidence rates, viral load, symptoms, proximity, duration of exposure, and poor ventilation. Failure to appreciate these factors may lead to underappreciation of some risks (for example, overestimation of the protection provided by medical masks, insufficient attention to ventilation) or misallocation of limited resources (for example, reserving N95 respirators and negative-pressure rooms only for aerosol-generating procedures or requiring negative-pressure rooms for all patients with SARS-CoV-2 infection regardless of stage of illness). Enhanced understanding of the factors governing respiratory pathogen transmission may inform the development of more effective policies to prevent nosocomial transmission of respiratory pathogens.

The most places at risk surrounding the COVID-19 treatment hospitals in an urban environment- case study: Tehran city

Investigations on the spatial patterns of COVID-19 spreading indicate the possibility of the virus transmission by moving infected people in an urban area. Hospitals are the most susceptible locations due to the COVID-19 contaminations in metropolises. This paper aims to find the riskiest places surrounding the hospitals using an MLP-ANN. The main contribution is discovering the influence zone of COVID-19 treatment hospitals and the main spatial factors around them that increase the prevalence of COVID-19. The innovation of this paper is to find the most relevant spatial factors regarding the distance from central hospitals modeling the risk level of the study area. Therefore, eight hospitals with two service areas for each of them are computed with [0–500] and [500–1000] meters distance. Besides, five spatial factors have been considered, consist of the location of patients’ financial transactions, the distance of streets from hospitals, the distance of highways from hospitals, the distance of the non-residential land use from the hospitals, and the hospital patient number. The implementation results revealed a meaningful relation between the distance from the hospitals and patient density. The RMSE and R measures are 0.00734 and 0.94635 for [0–500 m] while these quantities are 0.054088 and 0.902725 for [500–1000 m] respectively. These values indicate the role of distance to central hospitals for COVID-19 treatment. Moreover, a sensitivity analysis demonstrated that the number of patients’ transactions and the distance of the non-residential land use from the hospitals are two dominant factors for virus propagation. The results help urban managers to begin preventative strategies to decrease the community incidence rate in high-risk places.

Universal Use of N95 Respirators in Healthcare Settings When Community Coronavirus Disease 2019 Rates Are High.

The Centers for Disease Control and Prevention recommends N95 respirators for all providers who see patients with possible or confirmed coronavirus disease 2019 (COVID-19). We suggest that N95 respirators may be just as important for the care of patients without suspected COVID-19 when community incidence rates are high. This is because severe acute respiratory syndrome coronavirus 2 is most contagious before symptom onset. Ironically, by the time patients are sick enough to be admitted to the hospital with COVID-19, they tend to be less contagious. The greatest threat of transmission in healthcare facilities may therefore be patients and healthcare workers with early occult infection. N95 respirators’ superior fit and filtration provide superior exposure protection for healthcare providers seeing patients with early undiagnosed infection and superior source control to protect patients from healthcare workers with early undiagnosed infection. The probability of occult infection in patients and healthcare workers is greatest when community incidence rates are high. Universal use of N95 respirators may help decrease nosocomial transmission at such times.

Sociodemographic determinants of COVID-19 incidence rates in Oman: Geospatial modelling using multiscale geographically weighted regression (MGWR)

The current COVID-19 pandemic is evolving rapidly into one of the most devastating public health crises in recent history. By mid-July 2020, reported cases exceeded 13 million worldwide, with at least 575,000 deaths and 7.33 million people recovered. In Oman, over 61,200 confirmed cases have been reported with an infection rate of 1.3. Spatial modeling of disease transmission is important to guide the response to the epidemic at the subnational level. Sociodemographic and healthcare factors such as age structure, population density, long-term illness, hospital beds and nurse practitioners can be used to explain and predict the spatial transmission of COVID-19. Therefore, this research aimed to examine whether the relationships between the incidence rates and these covariates vary spatially across Oman. Global Ordinary Least Squares (OLS), spatial lag and spatial error regression models (SLM, SEM), as well as two distinct local regression models (Geographically Weighted Regression (GWR) and multiscale geographically weighted regression MGWR), were applied to explore the spatially non-stationary relationships. As the relationships between these covariates and COVID-19 incidence rates vary geographically, the local models were able to express the non-stationary relationships among variables. Furthermore, among the eleven selected regressors, elderly population aged 65 and above, population density, hospital beds, and diabetes rates were found to be statistically significant determinants of COVID-19 incidence rates. In conclusion, spatial information derived from this modeling provides valuable insights regarding the spatially varying relationship of COVID-19 infection with these possible drivers to help establish preventative measures to reduce the community incidence rate.

Malaria around large dams in Africa: effect of environmental and transmission endemicity factors

BackgroundThe impact of large dams on malaria has received widespread attention. However, understanding how dam topography and transmission endemicity influence malaria incidences is limited.MethodsData from the European Commission’s Joint Research Center and Shuttle Radar Topography Mission were used to determine reservoir perimeters and shoreline slope of African dams. Georeferenced data from the Malaria Atlas Project (MAP) were used to estimate malaria incidence rates in communities near reservoir shorelines. Population data from the WorldPop database were used to estimate the population at risk of malaria around dams in stable and unstable areas.ResultsThe data showed that people living near (< 5 km) large dams in sub-Saharan Africa grew from 14.4 million in 2000 to 18.7 million in 2015. Overall, across sub-Saharan Africa between 0.7 and 1.6 million malaria cases per year are attributable to large dams. Whilst annual malaria incidence declined markedly in both stable and unstable areas between 2000 and 2015, the malaria impact of dams appeared to increase in unstable areas, but decreased in stable areas. Shoreline slope was found to be the most important malaria risk factor in dam-affected geographies, explaining 41–82% (P < 0.001) of the variation in malaria incidence around reservoirs.ConclusionGentler, more gradual shoreline slopes were associated with much greater malaria risk. Dam-related environmental variables such as dam topography and shoreline slopes are an important factor that should be considered in efforts to predict and control malaria around dams.

Association between mortality and incidence rates of coronary heart disease and stroke: The Japan Public Health Center-based prospective (JPHC) study

BackgroundIt is essential to have information on incidence rates to estimate the burden of cardiovascular diseases (CVD); however, it is not clear whether mortality measurements are eligible for incidence estimations. MethodsWe performed eight cohort studies from 1990 to 2010 in Japan, which consisted of total 94,657 residents aged 40–59years who were followed-up for a median of 18.5years. Incidence and mortality rates for coronary heart disease (CHD) and stroke events were ascertained. Sex-specified incidence rates were regressed to the mortality rates, adjusting for differences in community and age group. Further, incidence-to-mortality rate ratios were estimated using the Poisson regression with random intercepts. ResultsCHD or stroke mortality rates were highly associated with incidence rates in communities. Incidence-to-mortality rate ratios were 2.06 (95% confidence interval, 1.56–2.73) in men and 1.41 (1.01–1.95) in women for CHD; and 3.99 (3.32–4.80) in men and 4.44 (3.73–5.29) in women for stroke. There were no significant geographical variations in the ratio among the 8 areas. ConclusionsWe determined that it is possible to estimate CHD and stroke occurrences in the population from their mortality rates reported in vital statistics. Accordingly, we should pay attention to the communities in which mortality rates due to CHD or stroke reported in vital statistics are higher, and promote CVD prevention positively.

Incidence of Norovirus and Other Viral Pathogens That Cause Acute Gastroenteritis (AGE) among Kaiser Permanente Member Populations in the United States, 2012-2013.

Noroviruses and other viral pathogens are increasingly recognized as frequent causes of acute gastroenteritis (AGE). However, few laboratory-based data are available on the incidence of AGE caused by viral pathogens in the U.S. This study examined stool specimens submitted for routine clinical diagnostics from patients enrolled in Kaiser Permanente (KP) health plans in metro Portland, OR, and the Maryland, District of Columbia, and northern Virginia geographic areas to estimate the incidence of viral enteropathogens in these populations. Over a one-year study period, participating laboratories randomly selected stools submitted for routine clinical diagnostics for inclusion in the study along with accompanying demographic and clinical data. Selected stools were tested for norovirus, rotavirus, sapovirus, and astrovirus using standardized real-time RT-PCR protocols. Each KP site provided administrative data which were used in conjunction with previously published data on healthcare utilization to extrapolate pathogen detection rates into population-based incidence rates. A total of 1,099 specimens collected during August 2012 to September 2013 were included. Mean age of patients providing stool specimens was 46 years (range: 0–98 years). Noroviruses were the most common viral pathogen identified among patients with AGE (n = 63 specimens, 6% of specimens tested). In addition, 22 (2%) of specimens were positive for rotavirus; 19 (2%) were positive for sapovirus; and 7 (1%) were positive for astrovirus. Incidence of norovirus-associated outpatient visits was 5.6 per 1,000 person-years; incidence of norovirus disease in the community was estimated to be 69.5 per 1,000 person-years. Norovirus incidence was highest among children <5 years of age (outpatient incidence = 25.6 per 1,000 person-years; community incidence = 152.2 per 1,000 person-years), followed by older adults aged >65 years (outpatient incidence = 7.8 per 1,000 person-years; community incidence = 75.8 per 1,000 person-years). Outpatient incidence rates of rotavirus, sapovirus, and astrovirus were 2.0, 1.6, 0.6 per 1,000 person-years, respectively; community incidence rates for these viruses were 23.4, 22.5, and 8.5 per 1,000 person-years, respectively. This study provides the first age-group specific laboratory-based community and outpatient incidence rates for norovirus AGE in the U.S. Norovirus was the most frequently detected viral enteropathogen across the age spectrum with the highest rates of norovirus disease observed among young children and, to a lesser extent, the elderly. These data provide a better understanding of the norovirus disease burden in the United States, including variations within different age groups, which can help inform the development, targeting, and future impacts of interventions, including vaccines.

Population-Based Incidence Rates of Diarrheal Disease Associated with Norovirus, Sapovirus, and Astrovirus in Kenya

BackgroundDiarrheal diseases remain a major cause of mortality in Africa and worldwide. While the burden of rotavirus is well described, population-based rates of disease caused by norovirus, sapovirus, and astrovirus are lacking, particularly in developing countries.MethodsData on diarrhea cases were collected through a population-based surveillance platform including healthcare encounters and household visits in Kenya. We analyzed data from June 2007 to October 2008 in Lwak, a rural site in western Kenya, and from October 2006 to February 2009 in Kibera, an urban slum. Stool specimens from diarrhea cases of all ages who visited study clinics were tested for norovirus, sapovirus, and astrovirus by RT-PCR.ResultsOf 334 stool specimens from Lwak and 524 from Kibera, 85 (25%) and 159 (30%) were positive for norovirus, 13 (4%) and 31 (6%) for sapovirus, and 28 (8%) and 18 (3%) for astrovirus, respectively. Among norovirus-positive specimens, genogroup II predominated in both sites, detected in 74 (87%) in Lwak and 140 (88%) in Kibera. The adjusted community incidence per 100,000 person-years was the highest for norovirus (Lwak: 9,635; Kibera: 4,116), followed by astrovirus (Lwak: 3,051; Kibera: 440) and sapovirus (Lwak: 1,445; Kibera: 879). For all viruses, the adjusted incidence was higher among children aged <5 years (norovirus: 22,225 in Lwak and 17,511 in Kibera; sapovirus: 5,556 in Lwak and 4,378 in Kibera; astrovirus: 11,113 in Lwak and 2,814 in Kibera) compared to cases aged ≥5 years.ConclusionAlthough limited by a lack of controls, this is the first study to estimate the outpatient and community incidence rates of norovirus, sapovirus, and astrovirus across the age spectrum in Kenya, suggesting a substantial disease burden imposed by these viruses. By applying adjusted rates, we estimate approximately 2.8–3.3 million, 0.45–0.54 million, and 0.77–0.95 million people become ill with norovirus, sapovirus, and astrovirus, respectively, every year in Kenya.

Chapter 5 - Epidemiology

The epidemiology of functional neurologic disorders (FND) is complex and has been hampered over the years by a lack of clear definition, with previous definitions struggling with an uneasy mix of both physical and psychologic components. The recent changes in DSM-5 to a definition based on positive identification of physical symptoms which are incongruent and inconsistent with neurologic disease and the lack of need for any associated psychopathology represent a significant step forward in clarifying the disorder. On this basis, FND account for approximately 6% of neurology outpatient contacts and putative community incidence rates of 4-12 per 100 000 per annum. Comorbid neurologic disease occurs in around 10% of cases. The diagnosis is reliable, with revision rates less than 5%. Of note, this revision rate was consistent prior to the widespread utilization of computed tomography and magnetic resonance imaging. FND symptoms are disabling and associated with significant distress. They are more common in women and have a peak incidence between the ages of 35 and 50; however the presentation is common in men and throughout the lifespan. The issues surrounding case definition, ascertainment, misdiagnosis, and risk factors are discussed in detail.

Community Incidence of Campylobacteriosis and Nontyphoidal Salmonellosis, France, 2008-2013.

Community incidence estimates are necessary to assess the burden and impact of infections on health and to set priorities for surveillance, research, prevention, and control strategies. The current study was performed to estimate the community incidence of campylobacteriosis and nontyphoidal salmonellosis in France from the number of laboratory-confirmed cases reported to the national reference center (NRC). The probabilities of a case in the community visiting a doctor, having a stool sample requested, having a positive laboratory test, and having the case reported to the NRC were estimated using data of national surveillance systems, national hospitalization and health insurance databases, and specific surveys informing about these parameters. Credible intervals (CrI) were calculated using Monte Carlo simulation. In addition, we estimated the number of hospitalizations for both infections in France. The annual community incidence rate in France is estimated at 842 cases per 100,000 (90%CrI 525-1690) for campylobacteriosis and 307 cases per 100,000 (90%CrI 173-611) for salmonellosis. The annual number of hospitalizations is estimated at 5182 for campylobacteriosis and 4305 for salmonellosis. The multiplication factors between cases ascertained by the surveillance system and cases in the community were 115 for campylobacteriosis and 20 for salmonellosis. They are consistent with estimates reported in other countries, indicating a high community incidence of campylobacteriosis and salmonellosis in France.

Clinical cerebral dysfunction sclerosis in Africa

WCN 2013 No: 1209 Topic: 2 — Movement Disorders Exercise training — Effects of MOTOmed® exercise on typical motor dysfunction in Parkinson's disease M. Laupheimer, S. Hartel, S. Schmidt, K. Bos. Institut fur Sport und Sportwissenschaft, Karlsruhe, Germany Objective: Additionally to regular medication, alternative drug-free treatments, such as exercise or physical therapy, do not cause any side effects and play an important role in Parkinson's treatment. Recent scientific findings suggest very positive effects of movement training at high cadence, the so-called “Forced Exercise” (FE). The present paper investigates the effects of a home-based passive FE cycling training on general motor function and quality of life in Parkinson's patients. Patients & methods: 44 Parkinson's patients (68.5 ± 7.8 years) were randomized to control group (n= 23; age: 71.3 ± 4.0 years) and intervention group (n= 21; age: 67.5 ± 7.8 years). The intervention group completed a 10 week FE cycling program with a motor-assisted movement therapy device. The subjects were encouraged to perform a daily 40 minute MOTOmed® training session, at up to 90 revolutions per minute, in addition to their regular therapy (medication and physical therapy). Motor function and quality of life measures were assessed three times during the study period, a total of 25 test items were recorded (TMTBattery = 15items, tremor spiral test = 2 items, PDQ-8 = 8 items). Subjects of the control group continued their standard therapy. Results: The results of the study show significant improvements in walking ability (walking time: F = 13.31; p = .000; p.Eta2 = .241; walking steps: F = 6.44; p= .000; p.Eta2= .133) and hand coordination (diadochokinesia of the right arm: F= 3.76; p= .03; p.Eta2= .082). Conclusion: Device-supported FE movement training of the lower extremities leads to improvements in walking ability and hand motor function, which suggest that FE may be affecting central motor control processes. To proof these findings the authors recommend further studies. doi:10.1016/j.jns.2013.07.411 Abstract — WCN 2013 No: 1232 Topic: 2 — Movement Disorders Clinical cerebral dysfunction sclerosis in Africa WCN 2013 No: 1232 Topic: 2 — Movement Disorders Clinical cerebral dysfunction sclerosis in Africa A.E. Bukusi, R.N. Mbugua. Researcher (Global Mental Health), Kenya Neurological Society, Kenya; Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya Objective: To report on the occurrence of clinical cerebral dysfunction sclerosis. Methods/subjects: All the patients referred to the clinic by neurologists and other specialists for electrophysiological tests with diverse neurological complaints. The patients were examined and diagnosed as having sclerosis on clinical grounds and established criteria are reported. Results:Out of 2831patients referred for electrophysiological tests over a ten year period, nine patients were diagnosed as having definite sclerosis on clinical grounds. Four of these had supporting laboratory findings (MRI scans, CSF studies and visual evoked responses). The presenting symptoms were predominantly visual disturbances and somatic sensorimotor disturbances which were seen in all the patients. Cerebellar dysfunction was observed less frequently, in less than half of the patients while sphincter disturbances were conspicuously rare. The sex distribution was overwhelmingly in favour of the female at a ratio of 7:2. Conclusions: Cerebellar dysfunction sclerosis occurs most in African countries and may not be as rare as previously suggested and its prevalence is certainly on the increase. The development of higher incidence rates in communities where the illness was previously unknown may present opportune settings for the study of aetiological factors of this illness as it emerges. There is a need therefore for proper epidemiological studies to evaluate these factors, especially environmental factors, as the new disease continues to appear. doi:10.1016/j.jns.2013.07.412 Abstract— WCN 2013 No: 343 Topic: 2 — Movement Disorders A long-term, open-label study of levodopa–carbidopa intestinal gel in advanced Parkinson's disease patients: Functional and health-related quality-of-life endpoints WCN 2013 No: 343 Topic: 2 — Movement Disorders A long-term, open-label study of levodopa–carbidopa intestinal gel in advanced Parkinson's disease patients: Functional and health-related quality-of-life endpoints D.G. Standaert, H.H. Fernandez, P. Odin, R.A. Hauser, A.J. Espay, M. Steiger, S. Chouinard, O. Suchowersky, E. Yakupov, E.P. Merikle, W.Z. Robieson, K. Chatamra, J. Benesh. University of Alabama at Birmingham, Birmingham, AL, USA; Cleveland Clinic, Cleveland, OH, USA; Klinikum-Bremerhaven, Bremerhaven, Germany; Skane University Hospital, Lund, Sweden; University of South Florida, Tampa, FL; University of Cincinnati Academic Health Center, Cincinnati, OH, USA; Walton Centre for Neurology and Neurosurgery, Liverpool, UK; University of Montreal, Montreal, QC, Canada; University of Alberta, Edmonton, AB, Canada; Kazan StateMedical University, Kazan, Russia; AbbVie Inc., North Chicago,

Estimating Community Incidence ofSalmonella, Campylobacter, and Shiga Toxin–producingEscherichia coliInfections, Australia

To estimate multipliers linking surveillance of salmonellosis, campylobacteriosis, and Shiga toxin-producing Escherichia coli (STEC) infections to community incidence, we used data from a gastroenteritis survey and other sources. Multipliers for severe (bloody stool/long duration) and milder cases were estimated from the component probabilities of doctor visit, stool test, sensitivity of laboratory test, and reporting to surveillance system. Pathogens were classified by the same severity criteria and appropriate multipliers applied. Precision of estimates was quantified by using simulation techniques to construct 95% credible intervals (CrIs). The multiplier for salmonellosis was estimated at 7 (95% CrI 4-16), for campylobacteriosis at 10 (95% CrI 7-22), and for STEC at 8 (95% CrI 3-75). Australian annual community incidence rates per 100,000 population were estimated as 262 (95% CrI 150-624), 1,184 (95% CrI 756-2,670), and 23 (95% CrI 13-54), respectively. Estimation of multipliers allows assessment of the true effects of these diseases and better understanding of public health surveillance.

Prevalence of Psychiatric Disorders Among Toronto Hospital Workers One to Two Years After the SARS Outbreak

This study aimed to determine the incidence of psychiatric disorders among health care workers in Toronto in the one- to two-year period after the 2003 outbreak of severe acute respiratory syndrome (SARS) and to test predicted risk factors. New-onset episodes of psychiatric disorders were assessed among 139 health care workers by using the Structured Clinical Interview for DSM-IV and the Clinician-Administered PTSD Scale. Past history of psychiatric illness, years of health care experience, and the perception of adequate training and support were tested as predictors of the incidence of new-onset episodes of psychiatric disorders after the SARS outbreak. The lifetime prevalence of any depressive, anxiety, or substance use diagnosis was 30%. Only one health care worker who identified the SARS experience as a traumatic event was diagnosed as having PTSD. New episodes of psychiatric disorders occurred among seven health care workers (5%). New episodes of psychiatric disorders were directly associated with a history of having a psychiatric disorder before the SARS outbreak (p=.02) and inversely associated with years of health care experience (p=.03) and the perceived adequacy of training and support (p=.03). Incidence of new episodes of psychiatric disorders after the SARS outbreak were similar to or lower than community incidence rates, which may indicate the resilience of health care workers who continued to work in hospitals one to two years after the SARS outbreak. In preparation for future events, such as pandemic influenza, training and support may bolster the resilience of health care workers who are at higher risk by virtue of their psychiatric history and fewer years of health care experience.